Annual Total Expenses
$7.81 M
+$4.34 M+124.80%
December 31, 2023
Summary
- As of February 8, 2025, CRVO annual total expenses is $7.81 million, with the most recent change of +$4.34 million (+124.80%) on December 31, 2023.
- During the last 3 years, CRVO annual total expenses has fallen by -$8.16 million (-51.09%).
- CRVO annual total expenses is now -77.13% below its all-time high of $34.16 million, reached on December 1, 1999.
Performance
CRVO Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$5.40 M
+$2.40 M+80.17%
September 30, 2024
Summary
- As of February 8, 2025, CRVO quarterly total expenses is $5.40 million, with the most recent change of +$2.40 million (+80.17%) on September 30, 2024.
- Over the past year, CRVO quarterly total expenses has increased by +$2.80 million (+107.96%).
- CRVO quarterly total expenses is now -56.15% below its all-time high of $12.31 million, reached on June 1, 2000.
Performance
CRVO Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
CRVO Total Expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +124.8% | +108.0% |
3 y3 years | -51.1% | +108.0% |
5 y5 years | -35.0% | +108.0% |
CRVO Total Expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -51.3% | +124.8% | at high | +496.9% |
5 y | 5-year | -51.3% | +124.8% | at high | +496.9% |
alltime | all time | -77.1% | >+9999.0% | -56.1% | +590.4% |
CervoMed Total Expenses History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $5.40 M(+80.2%) |
Jun 2024 | - | $3.00 M(+15.4%) |
Mar 2024 | - | $2.59 M(+4.6%) |
Dec 2023 | $7.81 M(+124.8%) | $2.48 M(-7.3%) |
Sep 2023 | - | $2.68 M(+117.3%) |
Jun 2023 | - | $1.23 M(-13.7%) |
Mar 2023 | - | $1.43 M(+51.9%) |
Dec 2022 | $3.48 M(-78.3%) | - |
Dec 2022 | - | $938.80 K(+3.8%) |
Sep 2022 | - | $904.10 K(-78.7%) |
Jun 2022 | - | $4.25 M(-6.8%) |
Mar 2022 | - | $4.55 M(+31.4%) |
Dec 2021 | $16.04 M(+0.4%) | $3.47 M(-14.5%) |
Sep 2021 | - | $4.05 M(+5.8%) |
Jun 2021 | - | $3.83 M(-18.2%) |
Mar 2021 | - | $4.68 M(+14.6%) |
Dec 2020 | $15.97 M(+38.3%) | $4.09 M(-22.5%) |
Sep 2020 | - | $5.27 M(+44.2%) |
Jun 2020 | - | $3.66 M(+23.8%) |
Mar 2020 | - | $2.96 M(-0.1%) |
Dec 2019 | $11.55 M(-4.0%) | $2.96 M(-3.0%) |
Sep 2019 | - | $3.05 M(+16.4%) |
Jun 2019 | - | $2.62 M(-10.2%) |
Mar 2019 | - | $2.92 M(+3.7%) |
Dec 2018 | $12.03 M(+6.0%) | $2.81 M(+1.0%) |
Sep 2018 | - | $2.79 M(-9.5%) |
Jun 2018 | - | $3.08 M(-8.1%) |
Mar 2018 | - | $3.35 M(+36.6%) |
Dec 2017 | $11.35 M(-38.2%) | $2.45 M(-26.7%) |
Sep 2017 | - | $3.35 M(+12.2%) |
Jun 2017 | - | $2.98 M(+16.1%) |
Mar 2017 | - | $2.57 M(+1.0%) |
Dec 2016 | $18.37 M(+186.8%) | $2.54 M(-56.2%) |
Sep 2016 | - | $5.80 M(+52.6%) |
Jun 2016 | - | $3.80 M(-38.9%) |
Mar 2016 | - | $6.22 M(+142.2%) |
Dec 2015 | $6.41 M(-19.4%) | $2.57 M(+90.8%) |
Sep 2015 | - | $1.35 M(+3.7%) |
Jun 2015 | - | $1.30 M(+8.8%) |
Mar 2015 | - | $1.19 M(-5.2%) |
Dec 2014 | $7.94 M | $1.26 M(-64.2%) |
Sep 2014 | - | $3.51 M(+94.9%) |
Jun 2014 | - | $1.80 M(+31.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2014 | - | $1.37 M(-73.5%) |
Dec 2013 | $10.86 M(+53.0%) | $5.17 M(+400.6%) |
Sep 2013 | - | $1.03 M(-73.4%) |
Jun 2013 | - | $3.88 M(+399.9%) |
Mar 2013 | - | $776.50 K(-23.3%) |
Dec 2012 | $7.10 M(-42.7%) | $1.01 M(-32.3%) |
Sep 2012 | - | $1.49 M(-35.6%) |
Jun 2012 | - | $2.32 M(+2.2%) |
Mar 2012 | - | $2.27 M(-46.7%) |
Dec 2011 | $12.38 M(+76.2%) | $4.26 M(-2.9%) |
Sep 2011 | - | $4.39 M(+113.5%) |
Jun 2011 | - | $2.06 M(+22.8%) |
Mar 2011 | - | $1.67 M(-29.3%) |
Dec 2010 | $7.03 M(+138.3%) | $2.37 M(+44.1%) |
Sep 2010 | - | $1.64 M(-9.7%) |
Jun 2010 | - | $1.82 M(+52.2%) |
Mar 2010 | - | $1.20 M(-5.8%) |
Dec 2009 | $2.95 M(+136.3%) | $1.27 M(+123.5%) |
Sep 2009 | - | $567.80 K(+33.4%) |
Jun 2009 | - | $425.70 K(+11.8%) |
Mar 2009 | - | $380.90 K(-10.3%) |
Dec 2008 | $1.25 M(+2135.8%) | $424.60 K(+47.3%) |
Sep 2008 | - | $288.20 K(+23.0%) |
Jun 2008 | - | $234.40 K(-22.0%) |
Mar 2008 | - | $300.40 K(-127.3%) |
Dec 2007 | $55.80 K(+33.2%) | -$1.10 M(-440.7%) |
Sep 2007 | - | $323.00 K(-16.9%) |
Jun 2007 | - | $388.80 K(-12.5%) |
Mar 2007 | - | $444.50 K(+1329.3%) |
Dec 2006 | $41.90 K(-54.6%) | $31.10 K(+763.9%) |
Sep 2006 | - | $3600.00(-91.9%) |
Jun 2006 | - | $44.70 K(+1141.7%) |
Mar 2006 | - | $3600.00(-100.0%) |
Dec 2005 | $92.20 K(-99.7%) | - |
Sep 2000 | - | $8.96 M(-27.2%) |
Jun 2000 | - | $12.31 M(+33.3%) |
Mar 2000 | - | $9.23 M(-11.8%) |
Dec 1999 | $34.16 M(+25.1%) | $10.46 M(+47.4%) |
Sep 1999 | - | $7.10 M(-22.0%) |
Jun 1999 | - | $9.10 M(+19.7%) |
Mar 1999 | - | $7.60 M(+8.6%) |
Dec 1998 | $27.30 M | $7.00 M(-11.4%) |
Sep 1998 | - | $7.90 M |
FAQ
- What is CervoMed annual total expenses?
- What is the all time high annual total expenses for CervoMed?
- What is CervoMed annual total expenses year-on-year change?
- What is CervoMed quarterly total expenses?
- What is the all time high quarterly total expenses for CervoMed?
- What is CervoMed quarterly total expenses year-on-year change?
What is CervoMed annual total expenses?
The current annual total expenses of CRVO is $7.81 M
What is the all time high annual total expenses for CervoMed?
CervoMed all-time high annual total expenses is $34.16 M
What is CervoMed annual total expenses year-on-year change?
Over the past year, CRVO annual total expenses has changed by +$4.34 M (+124.80%)
What is CervoMed quarterly total expenses?
The current quarterly total expenses of CRVO is $5.40 M
What is the all time high quarterly total expenses for CervoMed?
CervoMed all-time high quarterly total expenses is $12.31 M
What is CervoMed quarterly total expenses year-on-year change?
Over the past year, CRVO quarterly total expenses has changed by +$2.80 M (+107.96%)